{"nct_id":"NCT03703310","title":"Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)","status":"COMPLETED","status_verified_date":"2021-03","start_date":"2019-02-19","start_date_type":"ACTUAL","primary_completion_date":"2020-12-28","primary_completion_date_type":"ACTUAL","completion_date":"2020-12-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SLGL"]}